Pfizer Inc
NYSE: PFE
$26.02
-$0.70 (-2.6%)
Closing Price on November 14, 2024
PFE Articles
The U.S. Food and Drug Administration on Thursday published a list of brand-name drug companies that the agency has received complaints against for obstructing development of generic versions of...
Published:
Last Updated:
UnitedHealth, Walmart, Pfizer, and DowDuPont did their best to pin a small gain on the Dow Monday.
Published:
Last Updated:
The April 30 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Last Updated:
Pfizer, Merck, McDonald's, and Coca-Cola were the big losers Tuesday among the 30 Dow stocks.
Published:
Last Updated:
Pfizer reported mixed first-quarter financial results and full-year guidance before the markets opened on Tuesday.
Published:
Last Updated:
Both Pfizer and Merck are scheduled to release their most recent quarterly results before the markets open on Tuesday. These are the two biggest companies in the pharma industry and they can set the...
Published:
Last Updated:
24/7 Wall St. has put together a preview of Apple, McDonald's, Pfizer and other Dow companies scheduled to report their quarterly results this week.
Published:
Last Updated:
The April 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Published:
Last Updated:
Rheumatoid arthritis is an autoimmune disease that attacks tissues within the joints, and it is a major target of U.S. and foreign biotechnology and pharmaceutical companies.
Published:
Last Updated:
Pfizer shares were relatively muted after the pharma giant provided an update for its late-stage kidney trial.
Published:
Last Updated:
The March 29 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Last Updated:
Judging by the most shorted stocks traded on the New York Stock Exchange between the March 15 and March 29 settlement dates, short sellers were focused on a couple of favorites.
Published:
Last Updated:
Pfizer shares took a small step back on Monday despite announcing positive results from a late-stage trial. The pullback seems to be the product of overall market sentiment as opposed to these...
Published:
Last Updated:
The March 15 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Published:
Last Updated:
Judging by the most shorted stocks traded on the New York Stock Exchange between the February 28 and March 15 settlement dates, short sellers were stocking up on some favorites.
Published:
Last Updated: